Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
EHA Panel

EHA Panel

Videotallenne: Korkea-annoksisen influenssarokotteen (Efluelda Tetra) oikea ja turvallinen käyttö hoitajan näkökulmasta

Videotallenne: Korkea-annoksisen influenssarokotteen (Efluelda Tetra) oikea ja turvallinen käyttö hoitajan näkökulmasta

 TEMD 2024 Kılavuzu T2DM tedavisinde insülinizasyon önerileri

TEMD 2024 Kılavuzu T2DM tedavisinde insülinizasyon önerileri

RSV - respirační syncytiální virus

RSV - respirační syncytiální virus

V dokumentu na stažení se dozvíte více o RSV

El efecto de los antibióticos y aplicaciones de ENTEROGERMINA como solución terapéutica

El efecto de los antibióticos y aplicaciones de ENTEROGERMINA como solución terapéutica

Cómo afectan los antibióticos al organismo, y de qué manera, las esporas inteligentes de ENTEROGERMINA ayuda a contrarrestar y mejorar los síntomas negativos de estos.

Highlights från ERS 2024, Wien, 7-11 september

Highlights från ERS 2024, Wien, 7-11 september

Symposierapporter Sanofi

Sanofi har med hjälp av AI-verktyg förkortat texterna till sammanfattningar samt översatt dem till svenska.

Frame of Mind Campaign - Hypoglycaemia and its consequences

Frame of Mind Campaign - Hypoglycaemia and its consequences

Frame of Mind Campaign - Hypoglycaemia and its consequences

Frame of mind Campaign - Implications of Hypoglycaemia

Frame of mind Campaign - Implications of Hypoglycaemia

Frame of mind Campaign - Implications of Hypoglycaemia

Exploring the Effectiveness of GLA-300 in people inadequately controlled with a GLP-1 RA with Prof. Robert Ritzel

Exploring the Effectiveness of GLA-300 in people inadequately controlled with a GLP-1 RA with Prof. Robert Ritzel

2024 ATTD Expert Booth Talk with Prof. Robert Ritzel

Second generation basal insulins in Type 2 Diabetes Mellitus with Prof. Robert Ritzel

Second generation basal insulins in Type 2 Diabetes Mellitus with Prof. Robert Ritzel

Cardio-metabolic Axis Forum KOL Interview - Prof. Robert Ritzel

Framing the use of CGM metrics to assess clinical outcomes in T2DM patients receiving iGlarLixi with Prof. Viral Shah

Framing the use of CGM metrics to assess clinical outcomes in T2DM patients receiving iGlarLixi with Prof. Viral Shah

2024 ATTD Expert Booth Talk on iGlarLixi with Prof. Viral Shah

Management of cardiovascular risk factors for adults with T2DM - Prof. Joel Dave

Management of cardiovascular risk factors for adults with T2DM - Prof. Joel Dave

CMAF KOL Interview - Prof. Joel Dave